Szymanski P T, Goyal R K
Center for Swallowing and Motility Disorders, VA Medical Center, West Roxbury, Massachusetts 02132, USA.
Biochemistry. 1999 Mar 23;38(12):3778-84. doi: 10.1021/bi981394y.
Calponin (CaP) is a 34 kDa smooth muscle-specific protein that has been implicated in regulation of smooth muscle contractility. Two CaP binding sites on smooth muscle myosin rod have been recently described [Szymanski and Tao (1997) J.Biol.Chem. 272, 11142-11146]. We used a combination of cosedimentation, overlay, and fluorescence assays to determine the interaction between CaP and both subfragment 1 of myosin and isolated 20 kDa regulatory light chain of myosin (RLC). Subfragment 1, which was generated by cleavage of myosin with Staphylococcus aureus protease (myosin S1SA) inhibits cosedimentation of CaP with myosin filaments. Fluorescence assay showed that CaP labeled with fluorescent label (DAN-CaP) interacts with myosin S1SA in solution via a single class of binding sites. The binding constant (kaff) of this interaction at 50 mM NaCl is (2. 1 +/- 0.2) x 10(6) M-1 (n = 3). The interaction between DAN-CaP and myosin S1SA depends on ionic strength, and the EC50 of inhibition of this interaction occurs at about 130 mM NaCl. In contrast, the subfragment 1 that was generated by papain digestion (myosin S1PA), which cleaves RLC 4 kDa away from the NH2-terminal end of the molecule, does not interact with DAN-CaP. Overlay and fluorescent assay in solution showed that CaP binds to isolated RLC, suggesting that the interaction between CaP and subfragment 1 of myosin is due to a direct binding of CaP to RLC. CaP binding to myosin S1SA is stronger than to subfragment 2 in physiological salt concentrations. CaP binding to myosin head strengthened upon phosphorylation of RLC by Ca2+/calmodulin-dependent myosin light chain kinase. We suggest that CaP binds to subfragment 1 of myosin, exclusively via the NH2-terminal end of RLC, and this interaction could play a role in regulation of the actin-myosin interaction in smooth muscle contractility.
钙调蛋白(CaP)是一种34 kDa的平滑肌特异性蛋白,与平滑肌收缩性的调节有关。最近已描述了平滑肌肌球蛋白杆上的两个CaP结合位点[Szymanski和Tao(1997年)《生物化学杂志》272卷,11142 - 11146页]。我们使用了共沉降、覆盖和荧光测定相结合的方法来确定CaP与肌球蛋白的亚片段1以及分离出的20 kDa肌球蛋白调节轻链(RLC)之间的相互作用。通过用金黄色葡萄球菌蛋白酶切割肌球蛋白产生的亚片段1(肌球蛋白S1SA)抑制了CaP与肌球蛋白丝的共沉降。荧光测定表明,用荧光标记物标记的CaP(DAN - CaP)在溶液中通过一类结合位点与肌球蛋白S1SA相互作用。在50 mM NaCl条件下,这种相互作用的结合常数(kaff)为(2.1 ± 0.2)×10⁶ M⁻¹(n = 3)。DAN - CaP与肌球蛋白S1SA之间的相互作用取决于离子强度,这种相互作用抑制的半数有效浓度(EC50)出现在约130 mM NaCl处。相比之下,通过木瓜蛋白酶消化产生的亚片段1(肌球蛋白S1PA),它在离分子NH₂末端4 kDa处切割RLC,不与DAN - CaP相互作用。溶液中的覆盖和荧光测定表明CaP与分离出的RLC结合,这表明CaP与肌球蛋白亚片段1之间的相互作用是由于CaP与RLC的直接结合。在生理盐浓度下,CaP与肌球蛋白S1SA的结合比与亚片段2的结合更强。当RLC被Ca²⁺/钙调蛋白依赖性肌球蛋白轻链激酶磷酸化时,CaP与肌球蛋白头部的结合增强。我们认为,CaP仅通过RLC的NH₂末端与肌球蛋白的亚片段1结合,并且这种相互作用可能在平滑肌收缩性中肌动蛋白 - 肌球蛋白相互作用的调节中发挥作用。